What Happened to Trodusquemine? From Clinical Hope to Financial Setback
•
4 min read
Initial Phase I clinical trials for Trodusquemine showed good tolerability and promising results for metabolic conditions, but several planned Phase II trials were abruptly halted due to the original developer's financial collapse. This financial failure, not safety or efficacy issues, largely explains what happened to Trodusquemine's progress as a potential commercial drug.
